Inside Syngenta's Generic Defense: What Internal Documents Reveal About the Key AI Program

A judge in North Carolina denied Syngenta's motion for summary judgment in the FTC case surrounding its Key AI loyalty rebate program, which now sends the claims against Syngenta Crop Protection AG, Syngenta Corporation and Syngenta Crop Protection LLC to trial. The 87-page document does not state that Syngenta broke the law, but it is the most detailed public overview I have read of how Syngenta has been trying to defend molecules in a post patent world.

In September, Corteva settled the case, with a host of repercussions, limiting their ability to do things like tie payments to distributors for buying more than 50% of an active ingredient, run share-based programs that cap distributors’ generic purchases below 50% or use volume-based loyalty programs to recreate those share-based terms. You can read the full Upstream coverage of the settlement in the October 4th 2026 edition at heading 3b.

Syngenta's central argument is that Key AI Program should be judged under a price-cost test, under which above-cost discounts are generally treated as lawful, and that the single-AI markets the plaintiffs stated for azoxystrobin, mesotrione and metolachlor are not legally valid. The court has rejected both arguments at this stage, finding enough evidence for a jury to weigh in on the program.

The Judge stated that "there is evidence from which a reasonable jury could find that the program incentivizes the limited distributors to sell Syngenta AIs at higher prices than a purely competitive market would require while effectively dominating a significant share of the market.”

Interestingly, the court also rejected the defense that loyalty programs are simply how the industry works, stating that "there is no evidence that the distributors or the retailers require loyalty programs."

We all have known about the inbound generics, and unsurprisingly, Syngenta's own internal documents show it understood very well what generics would do to its pricing and margins.